Literature DB >> 15972876

Cardiovascular risk associated with celecoxib.

James M Brophy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15972876     DOI： 10.1056/NEJM200506233522519

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Gene expression profile of coronary artery cells treated with nonsteroidal anti-inflammatory drugs reveals off-target effects.

Authors:  Sanjeewani T Palayoor; Molykutty J-Aryankalayil; Adeola Y Makinde; David Cerna; Michael T Falduto; Scott R Magnuson; C Norman Coleman
Journal:  J Cardiovasc Pharmacol       Date:  2012-06       Impact factor: 3.105

2.  Time variations in the risk of myocardial infarction among elderly users of COX-2 inhibitors.

Authors:  Linda E Lévesque; James M Brophy; Bin Zhang
Journal:  CMAJ       Date:  2006-05-02       Impact factor: 8.262

3.  Inhibiting breast cancer by targeting the thromboxane A2 pathway.

Authors:  Haitao Li; Mee-Hyun Lee; Kangdong Liu; Ting Wang; Mengqiu Song; Yaping Han; Ke Yao; Hua Xie; Feng Zhu; Michael Grossmann; Margot P Cleary; Wei Chen; Ann M Bode; Zigang Dong
Journal:  NPJ Precis Oncol       Date:  2017-04-03

4.  Celecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery.

Authors:  Yonghyun Lee; Jungyun Kim; Wooseong Kim; Joon Nam; Seongkeun Jeong; Sunyoung Lee; Jin-Wook Yoo; Min-Soo Kim; Yunjin Jung
Journal:  Drug Des Devel Ther       Date:  2015-07-30       Impact factor: 4.162
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.